Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Product/Service

Anne Arundel Dermatology Adds Intelligent Scheduling Capabilities to Improve Patient Experience


Anne Arundel Dermatology (AADerm), a leading provider of medical, surgical, pathology, research and aesthetic dermatological services, announced today that it will add new intelligent patient scheduling tools, expanding its existing partnership with Relatient, a leading patient scheduling platform. Relatient's Dash Schedule solution will digitize and streamline historically manual and cumbersome processes for scheduling staff, while patient self-schedule capabilities will enable patients to easily schedule appointments at their own convenience, bypassing the need for phone calls or facilitation from AADerm's staff.

AADerm provides dermatological, pathology and research services across more than 119 locations in seven states. AADerm has partnered with Relatient for several years, leveraging its Dash Engage solution to send relevant text or email reminders to patients with a goal of improving engagement and reducing no-shows. In 2023 alone, Relatient facilitated more than 2.6 million reminders to AADerm patients, supporting over 1 million appointments across AADerm locations. However, as the organization has grown?adding 30 new practices across seven states since 2017? the existing process, characterized by limited system functionality and intricate scheduling exceptions, proved to be both time-consuming and cumbersome for staff.

Leaning on their already successful partnership, AADerm turned to Relatient to help solve this challenge. As the partnership expands, Relatient will deploy Dash Schedule across locations, digitizing provider preferences and information to automatically identify providers and availability according to patient and provider needs. Relatient's award-winning self-scheduling solution will also allow patients to schedule appointments easily themselves, further alleviating burden from call center staff.

"As an organization, we are hyper-focused on improving patient experiences. We pride ourselves on attentiveness to both clinical and interpersonal details that enable us to deliver the best care," said Vincent Bradley, CEO of Anne Arundel Dermatology. "As a key partner in this goal, Relatient has helped us better connect with patients and supported us through a large-scale practice management system migration. This, paired with Relatient's proven track record in patient scheduling, made it a no-brainer to expand our work. We look forward to leveraging Relatient's tools and expertise to further transform and standardize scheduling practices to benefit patients and staff at all our locations."

As AADerm aims to increase patient volume and move more than 20% of appointment scheduling to self-schedule processes, Relatient will help provide client service plans and optimization support while the tools are rolled out across locations. Intelligent scheduling tools will be available in AADerm practices as early as May 2024.

"Our partnership with Anne Arundel is designed to support strategic growth for this expanding multi-regional organization. We see them shifting to prioritize a great consumer experience in a way that more and more organizations will follow in the coming years," said Jeff Gartland, CEO of Relatient. "Patient experience, vendor consolidation and a strong focus on measurable improvement are all areas we anticipate will grow within larger multi-site provider organizations, management services organizations (MSOs) and other healthcare entities. We're thrilled to help Anne Arundel lead the way on these key initiatives."

About Anne Arundel Dermatology

Anne Arundel Dermatology is a leading provider of dermatological services in Maryland, Virginia, North Carolina, Florida, Tennessee, Pennsylvania and Georgia. Headquartered in Linthicum Heights, Maryland, and with approximately 119 locations and 260 providers, Anne Arundel Dermatology provides a comprehensive suite of dermatologic, pathology and research services, including general dermatology, advanced treatment options for skin cancer and aesthetic procedures. www.aadermatology.com

About Relatient, Inc.

Relatient, Inc., is the leading intelligent patient scheduling and engagement technology company that utilizes a data-led approach to improving access to care. Integrating with all leading EHR/PM systems, Relatient engages with over 50 million unique patients per year on behalf of provider groups and health systems across the U.S. Relatient's intelligent self-scheduling, patient messaging, chat, digital registration and payment solutions drive operational efficiency, increased appointments, reduced no-shows, faster patient payments and improved patient satisfaction, all while supporting better health and care quality initiatives. For more information, visit: http://www.relatient.com.


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: